Savient, Upsher-Smith Settle Oxandrin Patent Dispute
A federal judge has dismissed a patent lawsuit filed by Savient Pharmaceuticals Inc. over Upsher-Smith Laboratories Inc.'s generic version of weight-gain drug Oxandrin after the companies agreed to settle the case....To view the full article, register now.
Already a subscriber? Click here to view full article